Harrow (HROW) Operating Income (2010 - 2026)

Harrow's (HROW) quarterly Operating Income came in at -$22.1 million in Q1 2026, down 96.58% year-on-year from -$645.8 million in Q1 2025, and down 241.62% quarter-over-quarter from $15.6 million in Q4 2025.

Harrow (HROW) Operating Income (2010 - 2026) Analysis & Trends

Harrow's Operating Income history runs 17 years deep, the most recent figure standing at -$22.1 million for Q1 2026.

  • On a quarterly basis, Operating Income fell 96.58% year-over-year to -$22.1 million in Q1 2026; TTM through Mar 2026 was $19.7 million, a 335.3% increase from a year earlier, with the FY2025 full-year figure at $30.5 million, up 245.9% from the prior year.
  • Operating Income retreated to -$22.1 million in Q1 2026 per HROW's latest filing, from $15.6 million in the prior quarter.
  • Across five years, Operating Income topped out at $15.6 million in Q4 2025 and bottomed at -$22.1 million in Q1 2026.
  • The 5-year median for Operating Income is $1.5 million (2024), against an average of $1.2 million.
  • Across the five-year window, Operating Income jumped 1955.32% in 2023 and slumped 672.56% in 2024, its largest moves.
  • Year by year, Operating Income stood at -$1.8 million in 2022, then tumbled by 174.18% to -$4.9 million in 2023, then surged by 364.59% to $12.9 million in 2024, then increased by 20.87% to $15.6 million in 2025, then sank by 241.62% to -$22.1 million in 2026.
  • Per Business Quant, the three latest HROW Operating Income figures stand at -$22.1 million (Q1 2026), $15.6 million (Q4 2025), and $14.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 652.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 833.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.65 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 325.80 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -79.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 193.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 291.00 Mn
10 Harrow 1.56 Bn 1.47 Bn 27.05 Mn -22.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -22.08 Mn
Dec 31, 2025 15.59 Mn
Sep 30, 2025 14.75 Mn
Jun 30, 2025 11.41 Mn
Mar 31, 2025 -11.23 Mn
Dec 31, 2024 12.90 Mn
Sep 30, 2024 1.32 Mn
Jun 30, 2024 1.53 Mn
Mar 31, 2024 -6.93 Mn
Dec 31, 2023 -4.88 Mn
Sep 30, 2023 1.74 Mn
Jun 30, 2023 2.35 Mn
Mar 31, 2023 1.21 Mn
Dec 31, 2022 -1.78 Mn
Sep 30, 2022 -94,000.00
Jun 30, 2022 1.69 Mn
Mar 31, 2022 2.10 Mn
Dec 31, 2021 -1.76 Mn
Sep 30, 2021 -3.72 Mn
Jun 30, 2021 4.17 Mn